Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Blood Cancer Journal|April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphomaL F Porrata, K M Ristow, T M Habermann, et al.
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
Blood Cancer Journal|June 1, 2014
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomasR Briski, A L Feldman, N G Bailey, et al.
Leukemia|April 11, 2008
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomasA L Feldman, D X Sun, M E Law, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical featuresR Vaidya, T M Habermann, J H Donohue, et al.
Blood Cancer Journal|August 26, 2017
Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphomaS I Tracy, M J Maurer, T E Witzig, et al.
Blood Cancer Journal|November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trialsA Castellino, A Chiappella, B R LaPlant, et al.
Pageof 4